Vectors Research Management’s Quest Diagnostics DGX Stock Holding History

Vectors Research Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,400	Closed	-$219K	–	134
2022 Q4	$219K	Buy	+1,400	New	+$201K	0.06%	128
2022 Q3	–	Sell	-1,400	Closed	-$186K	–	227
2022 Q2	$186K	Hold	1,400	–	–	0.05%	148
2022 Q1	$192K	Sell	1,400 -100	-7%	-$13.9K	0.04%	149
2021 Q4	$260K	Buy	+1,500	New	+$228K	0.05%	146
2021 Q3	–	Sell	-1,400	Closed	-$185K	–	480
2021 Q2	$185K	Buy	+1,400	New	+$183K	0.05%	158
2020 Q4	–	Sell	-1,416	Closed	-$2K	–	445
2020 Q3	$2K	Buy	1,416 +1,400	+8,750%	+$165K	﹤0.01%	381
2020 Q2	$2K	Sell	16 -8	-33%	-$849	﹤0.01%	390
2020 Q1	$2K	Sell	24 -1,400	-98%	-$145K	﹤0.01%	423
2019 Q4	$152K	Buy	1,424 +1,400	+5,833%	+$146K	0.06%	120
2019 Q3	$3K	Hold	24	–	–	﹤0.01%	402
2019 Q2	$2K	Hold	24	–	–	﹤0.01%	384
2019 Q1	$2K	Hold	24	–	–	﹤0.01%	380
2018 Q4	$2K	Hold	24	–	–	﹤0.01%	593
2018 Q3	$3K	Buy	+24	New	+$2.63K	﹤0.01%	420

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vectors Research Management's DGX Position: Q1 2023 in Review

Vectors Research Management sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 1,400 shares — an estimated $219K sold.

Vectors Research Management first reported a position in DGX in Q3 2018 and held it in 14 quarters. The position peaked at $260K in Q4 2021. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

Vectors Research Management reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
Vectors Research Management sold 1,400 Quest Diagnostics shares in Q1 2023, an estimated $219K.
Vectors Research Management first reported a position in Quest Diagnostics in Q3 2018 and held it in 14 quarters.
Vectors Research Management's Quest Diagnostics position peaked at $260K in Q4 2021.
834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Vectors Research Management's 13F filing for Q1 2023, filed 4 May 2023.